Eye disease biotech gets cash boost
Year: 2025
Type: other
Source: C&EN Global Enterprise
Author: Asher Mullard, special to C&EN
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409217908
